Literature DB >> 22205317

Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial.

Tanvi S Sharma1, Lori J Bechard, Henry A Feldman, Robert Venick, Kathleen Gura, Catherine M Gordon, Andrew Sonis, Eva C Guinan, Christopher Duggan.   

Abstract

BACKGROUND: Children undergoing hematopoietic stem cell transplantation (HSCT) often require parenteral nutrition (PN) to optimize caloric intake. Standard approaches to nutritional supplementation provide 130-150% of estimated energy expenditure, but resting energy expenditure (REE) may be lower than expected after HSCT. Provision of PN exceeding energy needs may lead to overfeeding and associated complications.
OBJECTIVE: We conducted a blinded, randomized, controlled, multicenter trial in children undergoing HSCT to determine the effect on body composition of 2 different approaches of nutrition support: standard amounts of energy from PN (130-150% of REE) compared with PN titrated to match measured REE.
DESIGN: Twenty-six children undergoing HSCT were randomly assigned to standard or titrated PN. Energy intake was monitored until day 30 after HSCT. Body-composition and anthropometric measures were obtained through day 100. The primary outcome variable was percentage body fat (%BF) measured by dual energy X-ray absorptiometry.
RESULTS: The estimated change in %BF from baseline to day 30 was 1.2 ± 0.5% in the standard group and 0.1 ± 0.5% in the experimental group, but the overall time course of %BF did not differ significantly by treatment (P = 0.39 for time × treatment interaction). A profound loss of lean body mass (LBM) occurred in both groups during the intervention period and persisted through day 100.
CONCLUSIONS: Parenteral energy intake titrated to energy expenditure does not result in a lower accumulation of BF than does standard energy intake. Neither titrated nor standard PN regimens during HSCT preserve LBM. Alternative approaches to preserve LBM are needed. This trial is registered at clinicaltrials.gov as 00115258.

Entities:  

Mesh:

Year:  2011        PMID: 22205317      PMCID: PMC3260068          DOI: 10.3945/ajcn.111.026005

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  37 in total

Review 1.  Artificial nutrition in cancer patients: which route, what composition?

Authors:  F Bozzetti; C Gavazzi; L Mariani; F Crippa
Journal:  World J Surg       Date:  1999-06       Impact factor: 3.352

2.  Energy expenditure during allogeneic and autologous bone marrow transplantation.

Authors:  V Chamouard Cogoluenhes; C Chambrier; M Michallet; B Gordiani; J Y Ranchere; D Combret; Y Lallemand; M Roldan; M Accominoti; I Philip; J F Latour; G Hulewitz; P Biron; A Barbieux; P Bachmann
Journal:  Clin Nutr       Date:  1998-12       Impact factor: 7.324

3.  A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT.

Authors:  M Jarden; M T Baadsgaard; D J Hovgaard; E Boesen; L Adamsen
Journal:  Bone Marrow Transplant       Date:  2009-02-23       Impact factor: 5.483

4.  Body composition of a young, multiethnic, male population.

Authors:  K J Ellis
Journal:  Am J Clin Nutr       Date:  1997-12       Impact factor: 7.045

5.  Total parenteral nutrition on energy metabolism in children undergoing autologous peripheral blood stem cell transplantation.

Authors:  H Yamanaka; E Takeda; K Takata; E Syutou; K Miyamoto; T Watanabe; Y Kawano; Y Takaue; Y Kuroda
Journal:  J Med Invest       Date:  1998-02

6.  Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors.

Authors:  Kristen A Neville; Richard J Cohn; Katharine S Steinbeck; Karen Johnston; Jan L Walker
Journal:  J Clin Endocrinol Metab       Date:  2006-09-05       Impact factor: 5.958

7.  Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

Authors:  Joanna L Perkins; Alicia S Kunin-Batson; Nancy M Youngren; Kirsten K Ness; Kami J Ulrich; Melissa J Hansen; Anna Petryk; Julia Steinberger; Fiona S Anderson; K Scott Baker
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

8.  Prognostic factors in the resumption of oral dietary intake after allogeneic hematopoietic stem cell transplantation (HSCT) in children.

Authors:  Lori J Bechard; Eva C Guinan; Henry A Feldman; Vivian Tang; Christopher Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Jul-Aug       Impact factor: 4.016

9.  Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study.

Authors:  W Chemaitilly; F Boulad; K C Oeffinger; C A Sklar
Journal:  Bone Marrow Transplant       Date:  2009-03-23       Impact factor: 5.483

10.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

View more
  4 in total

1.  Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation.

Authors:  Lori J Bechard; Catherine Gordon; Henry A Feldman; Robert Venick; Kathleen Gura; Eva C Guinan; Christopher Duggan
Journal:  Pediatr Blood Cancer       Date:  2015-01-28       Impact factor: 3.167

2.  Body Composition in Children with Chronic Illness: Accuracy of Bedside Assessment Techniques.

Authors:  Enid E Martinez; Craig D Smallwood; Nicolle L Quinn; Katelyn Ariagno; Lori J Bechard; Christopher P Duggan; Nilesh M Mehta
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

3.  Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.

Authors:  Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-06       Impact factor: 2.839

4.  Attenuation of resting energy expenditure following hematopoietic SCT in children.

Authors:  L J Bechard; H A Feldman; R Venick; K Gura; C Gordon; A Sonis; N Mehta; E C Guinan; C Duggan
Journal:  Bone Marrow Transplant       Date:  2012-02-20       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.